(Q58834940)

title

Live tuberculosis vaccines based onphoPmutants: a step towards clinical trials (English)

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

author name string

Jesus A Gonzalo Asensio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

Ainhoa Arbués

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

Esther Pérez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

Brigitte Gicquel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

18 May 2020

language of work or name

English

0 references

publication date

14 January 2008

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

page(s)

201-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients

18 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The Development and Impact of Tuberculosis Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Origin and Interstate Spread of a New York City Multidrug-Resistant Mycobacterium tuberculosis Clone Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Global incidence of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

XDR Tuberculosis — Implications for Global Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

New drugs being developed for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Tuberculosis vaccines: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Has BCG attenuated to impotence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

BCG--different strains, different vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Genome plasticity of BCG and impact on vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Advances in tuberculosis vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Is the development of a new tuberculosis vaccine possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Developing an improved vaccine against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Prospects for a better vaccine against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Boosting vaccine for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Molecular genetics of Mycobacterium tuberculosis pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

21 January 2018

Recombinant BCG vaccines

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The use of mutant mycobacteria as new vaccines to prevent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Spread of extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

XDR-TB in South Africa: theory and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Global expression analysis of two-component system regulator genes during Mycobacterium tuberculosis growth in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The pleiotropic two-component regulatory system PhoP-PhoQ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

An essential role for phoP in Mycobacterium tuberculosis virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Neutral-red reaction is related to virulence and cell wall methyl-branched lipids in Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Mycobacterial trehalose-containing glycolipid with immunomodulatory activity on human CD4+ and CD8+ T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The contribution of immunology to the rational design of novel antibacterial vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Tuberculosis vaccine development: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Preclinical testing of new vaccines for tuberculosis: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Current progress in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Envisioning future strategies for vaccination against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

Development of new tuberculosis vaccines: a global perspective on regulatory issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.2.201

21 January 2018

Identifiers

DOI

10.1517/14712598.8.2.201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18194076%20AND%20SRC:MED&resulttype=core&format=json

18 May 2020

1 reference